🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/02/2015 7,85 7,89 7,58 7,74 -1,90% 3,95% 711.200
25/02/2015 7,62 7,90 7,21 7,89 +2,07% 9,06% 1.672.500
24/02/2015 7,84 8,06 7,56 7,73 -1,28% 6,38% 1.633.900
23/02/2015 7,49 8,01 7,43 7,83 +6,10% 7,74% 2.726.200
20/02/2015 7,12 7,48 7,10 7,38 +3,94% 5,34% 2.172.300
19/02/2015 7,11 7,26 7,01 7,10 -0,70% 3,52% 943.500
18/02/2015 7,11 7,30 6,95 7,15 +0,56% 4,92% 1.816.000
17/02/2015 6,75 7,40 6,75 7,11 +5,02% 9,63% 2.296.700
13/02/2015 6,60 6,80 6,56 6,77 +3,20% 3,64% 1.465.600
12/02/2015 6,40 6,64 6,26 6,56 +3,31% 5,94% 1.599.600
11/02/2015 6,33 6,44 6,15 6,35 +0,47% 4,58% 1.154.100
10/02/2015 6,25 6,72 6,21 6,32 +1,77% 8,16% 1.964.800
09/02/2015 6,49 6,53 6,15 6,21 -2,82% 5,86% 2.097.900
06/02/2015 6,65 6,95 6,27 6,39 -4,34% 10,23% 1.765.000
05/02/2015 6,24 6,77 6,17 6,68 +7,57% 9,62% 1.752.200
04/02/2015 6,33 6,39 6,14 6,21 -3,57% 3,95% 1.102.400
03/02/2015 6,15 6,48 6,07 6,44 +4,72% 6,67% 1.288.500
02/02/2015 6,31 6,32 6,01 6,15 -2,54% 4,91% 1.520.400
30/01/2015 6,52 6,66 6,30 6,31 -4,39% 5,52% 1.839.600
29/01/2015 6,64 6,67 6,38 6,60 -0,75% 4,29% 947.400
28/01/2015 6,79 6,87 6,58 6,65 -1,77% 4,27% 1.153.500
27/01/2015 6,79 7,03 6,60 6,77 +0,00% 6,33% 1.344.200
26/01/2015 6,37 6,82 6,35 6,77 +5,29% 7,30% 1.369.700
23/01/2015 6,57 6,64 6,31 6,43 -3,02% 5,02% 1.102.300
22/01/2015 6,42 6,74 6,12 6,63 -1,92% 9,66% 2.688.700
21/01/2015 7,17 7,28 6,60 6,76 -4,25% 9,48% 1.756.100
20/01/2015 6,95 7,19 6,86 7,06 +2,92% 4,73% 1.359.200
16/01/2015 6,54 6,90 6,53 6,86 +4,57% 5,64% 1.395.100
15/01/2015 6,66 6,95 6,42 6,56 -2,24% 7,96% 1.883.700
14/01/2015 6,16 6,75 6,02 6,71 +6,17% 11,85% 2.686.600